about
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosaCurrent and future treatments of secondary osteoporosis.Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies.Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.Clinical experience with microindentation in vivo in humans.Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation.An antimicrobial stewardship program reduces antimicrobial therapy duration and hospital stay in surgical wards.High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections.Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters.Brief Report: HIV Infection Is Associated With Worse Bone Material Properties, Independently of Bone Mineral Density.Differences in clinical features of two immigrant populations with tuberculosis.Acute cocaine intoxication and questionnaires.Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.Bone Density, Microarchitecture, and Tissue Quality Long-term After Kidney Transplant.Maintenance low dose systemic glucocorticoids have limited impact on bone strength and mineral density among incident renal allograft recipients: A pilot prospective cohort studyMicroindentation in the study of bone properties for type 1 diabetes mellitus patientsEarly diagnosis of fungal infections in lung transplant recipients, colonization versus invasive disease?High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections52-year-old man with recurrent urinary tract infection, Munchausen's syndromeCurrent State of the Diagnosis of Invasive Pulmonary Aspergillosis in Lung TransplantationChronic meningitis in a lung transplant recipientExtending cytomegalovirus prophylaxis in high-risk (D+/R-) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective studyCytokine profile in lung transplant recipients with Aspergillus spp colonizationHIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases
P50
Q36240813-899403E1-1C75-4027-917B-12B537C12FCDQ38272398-4F73B173-36AE-44C4-A63C-161056DCF23CQ38563889-18B7E7DF-15A0-49EC-90B0-DD4D68BBB81AQ38607555-F24C30BE-DE84-4075-85B1-F7C7B59D2141Q38795775-6EA60AC1-27BF-4C7B-BFDA-6213CEAB4CCAQ38927495-16BF69BC-C7EA-4762-9EEC-A5D78E6757F1Q39775388-4E2544DA-60D8-443F-8DDD-912029CFDD9FQ40177626-44BDD7DA-5123-416F-B80A-965642A7C29BQ40247196-0DD229F5-83FE-46B8-ACA2-CC3746A095ACQ40678434-E7C01147-F7CA-4D02-A1FA-29225C539381Q40683485-40A6E202-9680-4CD9-B000-E352A17F6CB0Q40779230-EE64AC21-EDF2-4DE0-9E0E-D3478F6D3DD1Q41706127-08DBE518-1D5F-46DD-96D9-D4F2EF55788FQ48139202-D761D780-CCEC-478C-B7E9-8B290606F76FQ50653568-5E490C25-A2CE-4D66-A50D-3CC54FEAB789Q51227313-B1B18F83-9943-4325-ACC8-92E38673CBE5Q56761501-61474E71-C43D-4BB1-AF34-75A42025F8DEQ59154495-3B954450-0EEF-4275-8AB1-5F5709BDEE72Q59154497-3E2C3478-DDD4-43B9-9A3C-7B9CA101BD1EQ59154501-85B9D111-E4CD-4BD4-B83B-3EE7901B7F47Q59154528-DDB438C9-51EF-4E01-967E-FA1644A82B1FQ61449853-9A72B8E1-5540-460A-AF0F-10AB07EC9413Q64055956-72A02C49-6683-42C4-85EB-05690B35BCB8Q90321714-3073C834-E56B-4EED-B385-C6EFE511F9A1Q91502924-4E2A7464-B97E-4F2E-92E9-EA6EEEDFBB28Q91971762-0272B901-90EB-46B9-B0DE-FFC41B9B5903
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sabina Herrera
@ast
Sabina Herrera
@en
Sabina Herrera
@es
Sabina Herrera
@sl
type
label
Sabina Herrera
@ast
Sabina Herrera
@en
Sabina Herrera
@es
Sabina Herrera
@sl
prefLabel
Sabina Herrera
@ast
Sabina Herrera
@en
Sabina Herrera
@es
Sabina Herrera
@sl
P106
P21
P2798
P31
P496
0000-0002-5057-354X